Drugmaker AstraZeneca has requested EU approval to acquire US rival Alexion Pharmaceuticals, according to an update today on the European Commission's register of deals.
The commission has set a July 5 deadline to decide on the deal.
AstraZeneca said it plans to buy Alexion for $39 billion, to establish a “greater scientific presence”